Previous Article | Next Article 
Journal of Clinical Microbiology, March 2002, p. 1124-1125, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.1124-1127.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Novel PCR-Probe Assay for Detection of and Discrimination between Legionella pneumophila and Other Legionella Species in Clinical Samples

LETTER
In recent years, several PCR-based methods for detection of
Legionella DNA have been described, but all PCR assays commonly
lacked the ability to discriminate between
Legionella pneumophila and other
Legionella species (
1-
3,
5). A recent study indicated
that
Legionella species other than
pneumophila may be important
in the etiology of community-acquired pneumonia (
4) and that
their prevalence may have been underestimated due to inadequate
diagnostic methods presently in use. To improve
Legionella detection
we designed a novel PCR-probe assay. The primer set, LEG1 (5'-TACCTACCCTTGACATACAGTG-3')
and LEG2 (5'-CTTCCTCCGGTTTGTCAC-3'), was derived from the 16S
rRNA gene sequence and used to amplify a 200-bp DNA fragment
specific for all
Legionella species. Probes LSPP-B (5'-GGTTGCGCTCGTTACG-3')
and LPN-B (5'-GAGTCCCCACCATCACATG-3') were selected to discriminate
L. pneumophila from other
Legionella species (with the exception
of
Legionella londonensis, which has a probe sequence identical
to that of
L. pneumophila).
The performance of the PCR-probe assay was investigated using a pool of negative clinical material spiked with 2.5 µl of positive control containing 2.5 or 1 L. pneumophila cell. As sensitivity and hybridization controls, 1-, 5, and 10-fg quantities of Legionella bozemanii, and Legionella tucsonensis chromosomal DNA were included. An inhibition control was included in each reaction. A negative control was included in each run. The PCR reaction mixture contained 10 pmol (each) of primers LEG1 and LEG2, 200 µM (each) deoxynucleoside triphosphate, 3 mM MgCl2, and 0.625 U of AmpliTaq Gold polymerase in 1x PCR buffer (Perkin-Elmer), in a final reaction volume of 25 µl. Samples were preheated for 10 min at 95°C, followed by 40 cycles of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C, with a final extension of 5 min at 72°C. Hybridization of the PCR product was carried out by spotting 3 µl of the sample on Hybond-N membrane (Amersham, Little Chalfont, United Kingdom). and hybridizing with Legionella species- and L. pneumophila-specific 5' biotinylated probes at 61°C (Fig. 1). PCR products were detected only when Legionella species were used as template and not with sequence-related organisms such as Pseudomonas aeruginosa, Lactobacillus casei, and Acinetobacter baumannii. The detection limit was at least 1 bacterial cell, 0.2 CFU, or 5 fg of chromosomal DNA per reaction.
The clinical specificity of the PCR-probe assay was assessed
using proteinase K-treated and boiled bronchoalveolar fluid
or sputum samples from 100 hospitalized patients with pneumonia.
Pneumonia was due to unknown (52%) or well-defined (48%) causes.
Among the known causes was a diagnosis of infection with
Aspergillus fumigatus,
Bordetella pertussis,
Chlamydia psittaci,
Chlamydia pneumoniae,
Haemophilus influenzae,
Klebsiella oxytoca,
Klebsiella pneumoniae,
L. pneumophila,
Moraxella catarrhalis,
Mycobacterium tuberculosis,
Mycoplasma pneumoniae,
Pseudomonas aeruginosa,
P. fluorescens,
Serratia marcescens,
Streptococcus pneumoniae,
cytomegalovirus, of respiratory syncytial virus. Five patients
were positive in the PCR-probe assay for
Legionella. In three
cases the PCR products also hybridized to the
L. pneumophila-specific
probe LPN-B. Those patients all had a positive culture for
Legionella.
The other 2 of 100 samples were positive for
Legionella species
other than
pneumophila. The PCR products were sequenced, and
after alignment to Genbank database sequences, these samples
were identified as
Legionella species with 98% homology to
Legionella waltersii and 97% homologies to
Legionella birminghamensis and
Legionella maceachernii, respectively. No alternative etiologic
agent was found in patients diagnosed with infection by
Legionella species other than
L. pneumophila. A collaborate prospective
study is intended to present a future validation of the PCR-probe
assay and to investigate the role of
Legionella species other
than
L. pneumophila in causing pneumonia.

ACKNOWLEDGMENTS
We gratefully acknowledge Hennie Maas (National Institute of
Public Health and Environment, Bilthoven, The Netherlands) for
providing type strains of
Legionella.

REFERENCES
1
- Ballard, A. L., N. K. Fry, L. Chan, S. B. Burman, J. V. Lee, T. G. Harrison, and K. J. Towner. 2000. Detection of Legionella pneumophila using a real-time PCR hybridization assay. J. Clin. Microbiol. 38:4215-4218.[Abstract/Free Full Text]
2
- Cloud, J. L., K. C. Caroll, P. Pixton, M. Erali, and D. R. Hillyard, 2000. Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation. J. Clin. Microbiol. 38:1709-1712.[Abstract/Free Full Text]
3
- Jonas, D., A., Rosenbaum, S., Weyrich, and S., Bhakdi, 1995. Enzyme-linked immunoassay for detection of PCR-amplified DNA of Legionellae in bronchoalveolar fluid. J. Clin. Microbiol. 33:1247-1252.[Abstract]
4
- McNally, C., B., Hackman, B. S., Fields, J. F., and Plouffe, 2000. Potential importance of Legionella species as etiologies in community aquired pneumonia (CAP). Diagn. Microbiol. Infect. Dis. 38:79-82.[CrossRef][Medline]
5
- Weir, S. C., S. H., Fischer, F., Stock, and J. G. Vee, 1998. Detection of Legionella by PCR in respiratory specimens using a commercially available kit. Am. J. Clin. Pathol. 110:295-300.[Medline]
| | | | | |
Anneke van der Zee Harold Verbakel Caroline de Jong Raymond Pot Anneke Bergmans Marcel Peeters
Laboratory of Medical Microbiology St. Elisabeth Hospital 5000AS Tilburg, The Netherlands
Peter Schneeberger
Laboratory of Medical Microbiology Bosch Medical Centre 5211NL Den Bosch, The Netherlands
Joop Schellekens
National Institute of Public Health and Environment 3720BA Bilthoven, The Netherlands
|
| | | | | |
|
Journal of Clinical Microbiology, March 2002, p. 1124-1125, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.1124-1127.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Diederen, B. M. W., Kluytmans, J. A. J. W., Vandenbroucke-Grauls, C. M., Peeters, M. F.
(2008). Utility of Real-Time PCR for Diagnosis of Legionnaires' Disease in Routine Clinical Practice. J. Clin. Microbiol.
46: 671-677
[Abstract]
[Full Text]
-
Bencini, M. A., van den Brule, A. J. C., Claas, E. C. J., Hermans, M. H. A., Melchers, W. J. G., Noordhoek, G. T., Salimans, M. M. M., Schirm, J., Vink, C., van der Zee, A., Jansen, R.
(2007). Multicenter Comparison of Molecular Methods for Detection of Legionella spp. in Sputum Samples. J. Clin. Microbiol.
45: 3390-3392
[Abstract]
[Full Text]
-
Diederen, B. M. W., de Jong, C. M. A., Marmouk, F., Kluytmans, J. A. J. W., Peeters, M. F., Van der Zee, A.
(2007). Evaluation of real-time PCR for the early detection of Legionella pneumophila DNA in serum samples. J Med Microbiol
56: 94-101
[Abstract]
[Full Text]
-
Diederen, B. M. W., Peeters, M. F.
(2006). Evaluation of Two New Immunochromatographic Assays (Rapid U Legionella Antigen Test and SD Bioline Legionella Antigen Test) for Detection of Legionella pneumophila Serogroup 1 Antigen in Urine.. J. Clin. Microbiol.
44: 2991-2993
[Abstract]
[Full Text]
-
Diederen, B. M. W., Kluytmans, J. A. J. W., Peeters, M. F.
(2006). Evaluation of Vircell Enzyme-Linked Immunosorbent Assay and Indirect Immunofluorescence Assay for Detection of Antibodies against Legionella pneumophila.. CVI
13: 361-364
[Abstract]
[Full Text]
-
Roig, J., Rello, J.
(2003). Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother
51: 1119-1129
[Abstract]
[Full Text]